EXHIBIT 99.1 E .i MultiPlan. MultiPlan Reports Third Quarter 2024 Results and Updates 2024 Guidance – Q3 2024 Revenues of $230.5 million, Net Loss of $391.5 million (including a $361.6 million impairment of goodwill and indefinite-lived intangibles), and Adjusted EBITDA of $141.6 million – Identified potential medical cost savings of approximately $6.4 billion in Q3 2024, up 10% from Q3 2023 and up 3% from Q2 2024 NEW YORK, NY — November 5, 2024 — MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE: ...

MultiPlan Corporation (MPLN) shares rallied 9% in the last trading session to close at $7.87. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 21.7% loss over the past four weeks. Rising optimism around MultiPlan's partnership with the National Rural Health Association is aiding the stock's recovery. Together, the two organizations are leveraging over 40 years of combined expertise, along with advanced technol ...

MultiPlan Corporation (NYSE:MPLN) Q2 2024 Earnings Conference Call August 1, 2024 9:30 AM ET Company Participants Shawna Gasik - Vice President of Investor Relations Travis Dalton - Chief Executive Officer Jim Head - Chief Financial Officer Jerry Hogge - Chief Operating Officer Conference Call Participants Joshua Raskin - Nephron Research Daniel Grosslight - Citigroup Madison Aron - JPMorgan Jessica Tassan - Piper Sandler Operator Good morning and welcome to the MultiPlan Corporation Second Quarter 2024 Ear ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2024 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39228 İMultiPlan. MULTIPLAN CORPORATION (Exact Name of Registrant as Specified in Its Charter) | --- | --- | --- | |------ ...

EXHIBIT 99.1 EASE .i MultiPlan. MultiPlan Reports Second Quarter 2024 Results and Updates 2024 Guidance – Q2 2024 Revenues of $233.5 million, Net Loss of $576.7 million (including a $553.7 million impairment of goodwill), and Adjusted EBITDA of $146.7 million – Identified potential medical cost savings of approximately $6.2 billion in Q2 2024, up 9% from Q2 2023 and up 8% from Q1 2024 – CFO transition plan announced NEW YORK, NY — August 1, 2024 — MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE: ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2024 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39228 MULTIPLAN CORPORATION (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorp ...

MultiPlan Corporation (MPLN Q1 2024 Earnings Conference Call May 8, 2024 8:00 AM ET Company Participants Shawna Gasik - Vice President, Investor Relations Travis Dalton - Chief Executive Officer Jim Head - Chief Financial Officer Conference Call Participants Joshua Raskin - Nephron Research LLC Operator Good morning, everyone and welcome to the MultiPlan Corporation First Quarter 2024 Earnings Call. My name is Angela, and I will be coordinating your call today. [Operator Instructions] I would now like to ha ...

2021 2024 'Gross sovings identified. Effective fourth quarter 2022, we modified the methodology for capturing and reporting medical charges processed and potential medical cost sovi reviously reported submissions. We believe this new methodology provides additional insight into our business, increases alignment with our revenue reporting, and will pro accurate portrayal of our portfollo of services as we grow our business through the addition of new claims flows and new service offerings. A full description ...

EXHIBIT 99.1 MultiPlan Reports First Quarter 2024 Results NEW YORK, NY — May 8, 2024 — MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the first quarter ended March 31, 2024. "As you heard me say a just few months ago, I joined as CEO because I saw an incredible opportunity to help ...

MultiPlan Corporation (NYSE:MPLN) Q4 2023 Earnings Conference Call February 29, 2024 8:00 AM ET Company Participants Shawna Gasik - Assistant Vice President of Investor Relations Dale White - President and Chief Executive Officer James Head - Executive Vice President and Chief Financial Officer Travis Dalton - Incoming Chief Executive Officer Conference Call Participants Joshua Raskin - Nephron Research Luismario Higuera - Citigroup Operator Hello everyone and welcome to the MultiPlan Corporation Fourth Qua ...